Patient Capital Management 13F, Q1 2025
Samantha McLemore · quarter ending 31 March 2025 · filed 14 May 2025 · SEC CIK 1854794
Common stock only: shares the fund reported owning at the quarter end, valued as filed.
Largest positions, Q1 2025
The 25 largest of 39 positions. Weights are against the whole filed book. Changes are in shares held, against the Q4 2024 filing.
| Company | Ticker | Value | % of book | vs Q4 2024 |
|---|---|---|---|---|
| AMAZON COM INC | AMZN | $109.21M | 5.6% | -6% shares |
| CITIGROUP INC | C | $99.75M | 5.1% | -9% shares |
| QXO INC | QXO | $98.64M | 5.1% | -6% shares |
| ALPHABET INC | GOOGL | $93.66M | 4.8% | unchanged |
| ROYALTY PHARMA PLC | $92.54M | 4.8% | +3% shares | |
| ENERGY TRANSFER L P | ET | $90.79M | 4.7% | -4% shares |
| CVS HEALTH CORP | CVS | $89.81M | 4.6% | +2% shares |
| META PLATFORMS INC | META | $83.96M | 4.3% | unchanged |
| IAC INC | PPLI | $77.39M | 4.0% | unchanged |
| GENERAL MTRS CO | GM | $71.80M | 3.7% | unchanged |
| ALIBABA GROUP HLDG LTD | BABA | $70.62M | 3.6% | -23% shares |
| NORWEGIAN CRUISE LINE HLDG L | $68.07M | 3.5% | +45% shares | |
| NVIDIA CORPORATION | NVDA | $67.95M | 3.5% | +3% shares |
| UBS GROUP AG | $62.58M | 3.2% | unchanged | |
| BIOGEN INC | BIIB | $62.35M | 3.2% | +10% shares |
| CROCS INC | CROX | $54.31M | 2.8% | +15% shares |
| ONEMAIN HLDGS INC | OMF | $52.42M | 2.7% | -15% shares |
| SEADRILL LTD | $49.32M | 2.5% | +18% shares | |
| EXPEDIA GROUP INC | EXPE | $46.87M | 2.4% | -37% shares |
| UNITED AIRLS HLDGS INC | UAL | $46.31M | 2.4% | -8% shares |
| MATTEL INC | MAT | $44.92M | 2.3% | -9% shares |
| FIDELITY WISE ORIGIN BITCOIN | FBTC | $44.64M | 2.3% | +103% shares |
| SOFI TECHNOLOGIES INC | SOFI | $41.11M | 2.1% | -17% shares |
| KOSMOS ENERGY LTD | KOS | $41.05M | 2.1% | +5% shares |
| DAVE & BUSTERS ENTMT INC | PLAY | $38.68M | 2.0% | +24% shares |
What changed since Q4 2024
Against the Q4 2024 filing, Patient Capital Management opened 3 new positions, added to 12, trimmed 14, left 10 unchanged and exited 7. Every position is compared, matched on its CUSIP; a change of 2% or less in shares counts as unchanged.
Other quarters
Source: SEC Form 13F-HR, accession 0001085146-25-003124, filed by Patient Capital Management, LLC. Values are as filed and cover US-listed positions only; a 13F does not show short positions or holdings outside the US. A 13F may be filed up to 45 days after the quarter ends, so the fund may have traded since. Educational information, not financial advice.